Abstract
A case of failure of cefepime treatment of a bloodstream infection with AmpC-producing Klebsiella pneumoniae is reported. The failure was attributed to extended-spectrum β-lactamase (ESBL) acquisition by the isolate, possibly during therapy. Problems encountered with ESBL detection in AmpC-producing isolates are discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 4891-4894 |
Number of pages | 4 |
Journal | Journal of clinical microbiology |
Volume | 43 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2005 |
All Science Journal Classification (ASJC) codes
- Microbiology (medical)